FDA
- Status: approved
🇺🇸 Aspirin combined with half-dose ticagrelor in United States
Aspirin combined with half-dose ticagrelor (Aspirin combined with half-dose ticagrelor) regulatory status in United States.
Marketing authorisation
Aspirin combined with half-dose ticagrelor in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Aspirin combined with half-dose ticagrelor approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Aspirin combined with half-dose ticagrelor in United States?
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School is the originator. The local marketing authorisation holder may differ — check the official source linked above.